刺
泛素连接酶
小分子
干扰素基因刺激剂
蛋白酶体
泛素
机制(生物学)
蛋白质降解
药物发现
计算生物学
生物
细胞生物学
化学
生物化学
胞浆
基因
酶
哲学
认识论
工程类
航空航天工程
作者
Merve Mutlu,Isabel Schmidt,Andrew I. Morrison,Benedikt Goretzki,Felix Freuler,Damien Bégué,Oliver Simić,Nicolas Pythoud,Erik Ahrné,Sandra Kapps,Susan Roest,Débora Bonenfant,Delphine Jeanpierre,Thi-Thanh-Thao Tran,Rob Maher,Shaojian An,Amandine Rietsch,Florian Nigsch,Andreas Hofmann,John Reece-Hoyes,Christian N. Parker,Danilo Guerini
标识
DOI:10.1038/s41467-024-48922-w
摘要
Abstract Stimulator of interferon genes (STING) is a central component of the cytosolic nucleic acids sensing pathway and as such master regulator of the type I interferon response. Due to its critical role in physiology and its’ involvement in a variety of diseases, STING has been a focus for drug discovery. Targeted protein degradation (TPD) has emerged as a promising pharmacology for targeting previously considered undruggable proteins by hijacking the cellular ubiquitin proteasome system (UPS) with small molecules. Here, we identify AK59 as a STING degrader leveraging HERC4, a HECT-domain E3 ligase. Additionally, our data reveals that AK59 is effective on the common pathological STING mutations, suggesting a potential clinical application of this mechanism. Thus, these findings introduce HERC4 to the fields of TPD and of compound-induced degradation of STING, suggesting potential therapeutic applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI